---
title: Esco Aster vs Omniabio
slug_a: escoaster
slug_b: omniabio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/escoaster/omniabio
---

# Esco Aster vs Omniabio

Side-by-side profile data from each company listing on this directory.

## Esco Aster

- Profile: [/companies/escoaster](/companies/escoaster)

Esco Aster — Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.

Services: 5. Modalities: 4. Indications: 4. Locations: 0. Certifications: 2. The strongest documented coverage currently appears in services (5).

### Services

- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- GLP Toxicology
- Clinical Trial Services
- Translational Research

### Modalities

- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Omniabio

- Profile: [/companies/omniabio](/companies/omniabio)

Omniabio — OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Cell-Line Development
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)